Neuro-Oncology News

First-line chemotherapy treatment appeared to significantly improve long-term survival among adults with medulloblastoma, according to a literature-based meta-analysis.

The FDA granted breakthrough status to an experimental treatment that uses the poliovirus to treat glioblastoma, an aggressive form of brain cancer.

Preliminary data from a small randomized study showed light therapy decreased depressive symptoms and normalized circadian rhythms among cancer survivors.

Heather S.L. Jim, PhD, of the health outcomes and behavior program at Moffitt Cancer Center, and colleagues analyzed data from previously published studies that examined spirituality and its association with outcomes among more than 32,000 patients with cancer. They found that patients with higher levels of spiritual well-being reported better emotional, physical and social health.

In team sports, home-field advantage appears to be a real phenomenon. Although the exact causes are not clear — despite having been extensively investigated — there seem to be intangible, difficult-to-define reasons why teams do better in familiar surroundings with a strong support system.

Nausea and vomiting are two of the most distressing and potentially debilitating effects of cancer treatment.

NEW ORLEANS — David Polsky, MD, PhD, professor of dermatology and pathology at NYU School of Medicine and NYU Langone Medical Center, offers insights into advances in liquid biopsy.

Yoga therapy is an integrative medicine technique that supplements the traditional treatment regimens patients with cancer undergo.

NEW ORLEANS — Kunle Odunsi, MD, PhD, FRCOG, FACOG, deputy director of Roswell Park Cancer Institute and executive director of the institute’s Center for Immunotherapy, spoke to HemOnc Today at the American Association for Cancer Research Annual Meeting about advances in the use of immunotherapy for cancer treatment.

The children of Hispanic mothers born outside the United States appeared to have reduced risk for several cancers, including glioma, astrocytoma, neuroblastoma and Wilms’ tumor, according to results of a population-based case–control study.